Jonathan F. Head
About
In The Last Decade
Jonathan F. Head
66 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 508
- Radiology, Nuclear Medicine and Imaging 504
- Oncology 371
- Physiology 314
- Mechanics of Materials 297
Countries citing papers authored by Jonathan F. Head
This map shows the geographic impact of Jonathan F. Head's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan F. Head with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan F. Head more than expected).
Fields of papers citing papers by Jonathan F. Head
This network shows the impact of papers produced by Jonathan F. Head. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan F. Head. The network helps show where Jonathan F. Head may publish in the future.
Co-authorship network of co-authors of Jonathan F. Head
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan F. Head. A scholar is included among the top collaborators of Jonathan F. Head based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan F. Head. Jonathan F. Head is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Schopenhauer and the Stoics | 0 |
| 2 | 29 | |
| 3 | 15 | |
| 4 | 48 | |
| 5 | 110 | |
| 6 | 40 | |
| 7 | Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. | 78 |
| 8 | 18 | |
| 9 | 15 | |
| 10 | Phase II trial of Ontak to deplete regulatory T cells in treatment-refractory stage III/IV ovarian cancer | 1 |
| 11 | 5 | |
| 12 | 23 | |
| 13 | Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. | 54 |
| 14 | 40 | |
| 15 | 36 | |
| 16 | 63 | |
| 17 | 80 | |
| 18 | 45 | |
| 19 | 3 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.